EcoDrugPlus

Histamine Receptor H2a

Ensembl ID : ENSONIG00000005017
Gene Symbol: HRH2A
1 Cross references
189 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSONIG00000008187
Gene Symbol: HDAC1
1 Cross references
255 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSONIG00000008796
Gene Symbol: HDAC10
4 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSONIG00000003256
Gene Symbol: HDAC11
4 Cross references
202 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSONIG00000011350
Gene Symbol: HDAC2
4 Cross references
209 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSONIG00000000966
Gene Symbol: HDAC4
4 Cross references
196 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSONIG00000004475
Gene Symbol: LOC100702792
4 Cross references
202 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSONIG00000006345
Gene Symbol: HDAC5
4 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSONIG00000000836
Gene Symbol: HDAC6
4 Cross references
180 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSONIG00000009184
Gene Symbol: HDAC7
3 Cross references
189 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSONIG00000011850
Gene Symbol: HDAC8
1 Cross references
205 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 1

Ensembl ID : ENSONIG00000020883
Gene Symbol: HCAR1
1 Cross references
233 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).